Navigation Links
Retinal Vein Occlusion Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Date:8/6/2012

Therapeutics, Prominent Sponsors, 2012 58

Table 34: Retinal Vein Occlusion Therapeutics, Global, Key Companies Participating Clinical Trials, 2012 59

Table 35: Regeneron - Ophthalmology Pipeline Products, 2012 63

Table 36: Novartis - Ophthalmology Pipeline Products, 2012 65

Table 37: Roche - Ophthalmology Pipeline Products, 2012 67

Table 38: Allergan, Inc. - Ophthalmology Pipeline Products, 2012 68

Table 39: Retinal Vein Occlusion Therapeutics, Global, Deals, 2009-2011 69

List of Figures

1.2 List of FiguresFigure 1: Branch Retinal Vein Occlusion 7Figure 2: Central Vein Retinal Occlusion 8Figure 3: Ischemic Central Retinal Vein Occlusion 8Figure 4: Nonischemic Central Retinal Vein Occlusion 9Figure 5: KOL Insights, Future Trends in the Prevalence for the RVO in the US and Europe 10Figure 6: Pharmacoeconomic Burden of Retinal Vein Occlusion 12Figure 7: Branch Retinal Vein Occlusion in the Superotemporal Quadrant of the Right Eye 15Figure 8: Nonperfused Central Retinal Vein Occlusion in the Left Eye 15Figure 9: Assessment of Cardiovascular Risk in Patients with Retinal Vein Occlusion 16Figure 10: KOL Insights, Treatment and Management Patterns 16Figure 11: KOL Insights, Usage Patterns for the Pharmacological Treatment Options 19Figure 12: Retinal Vein Occlusion Therapeutics Market, Global, Revenue ($m), 2006- 2011 23Figure 13: Retinal Vein Occlusion Therapeutics Market, Global, Forecast ($m), 2011- 2019 24Figure 14: Retinal Vein Occlusion Therapeutics Market, The US, , Revenue ($m), 2006- 2011 25Figure 15: Retinal Vein Occlusion Therapeutics Market, The US, Forecast ($m), 2011- 2019 26Figure 16: Retinal Vein Occlusion Therapeutics Market, France, Revenue ($m), 2006- 2011 27Figure 17: Retinal Vein Occlusion Therapeutics Market, France, Forecast ($m), 2011- 2019 28Figure 18: Retinal Vein Occlusion Therapeutics Market, Germany, Revenue ($m), 2006- 2011 29Figure 19: Retinal Vein Occlusion Therapeutics Market, Germany,
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
2. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
3. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
4. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
5. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
6. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
7. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
8. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
9. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
10. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
11. New Forecast Shows Global Protein Therapeutics Market to Reach $143.4 Billion by 2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... HILDEN , Deutschland, und ... , ... ermöglicht QIAGEN die Entwicklung von ... Genpanels, für Blutkrebs  Neuer Test ... Patienten mit Knochenmarkserkrankungen (myelodysplastischen Syndromen) einen günstigen ...
(Date:7/24/2014)...  Mettler-Toledo International Inc. (NYSE: MTD ) ... are the highlights: , Sales in local ... the prior year. Reported sales increased 5% which included ... per diluted share as reported (EPS) were $2.49, compared ... EPS was $2.57, an increase of 9% over the ...
(Date:7/24/2014)... -- IGI Laboratories, Inc. (NYSE MKT: IG), a ... company, today announced it has accepted  Damian Finio,s ... has accepted a senior level finance position at a ... of his new position, Mr. Finio will be unable ... Laboratories, Inc.  The effective date of his resignation will ...
Breaking Medicine Technology:QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 2QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 3QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 4QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 5Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 2Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 3Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 4Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 5Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 6Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 7Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 8Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 9Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 10Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 11Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 12Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 13Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 14IGI Laboratories, Inc. Announces Change To Its Board Of Directors 2
... 2012   OncoSec Medical Incorporated (OTCBB:ONCS), which ... ElectroOncology therapies to treat solid tumor cancers, today ... biomarker strategy with the goal of identifying and ... the selection of patients potentially responsive to the ...
... 8, 2012  S1 Pharmaceuticals, Inc., a developer of therapeutics for ... addition and Scientific Advisory Board appointment to strengthen and expand ... Pyke, MD, PhD, a member of the S1 Advisory Board ... Chief Medical Officer. , Molly A. Katz, MD was ...
Cached Medicine Technology:OncoSec to Evaluate Potential Predictive or Prognostic Biomarkers for Treatment of Solid Tumor Cancers Using OMS ElectroImmunotherapy 2OncoSec to Evaluate Potential Predictive or Prognostic Biomarkers for Treatment of Solid Tumor Cancers Using OMS ElectroImmunotherapy 3S1 Pharmaceuticals Announces New Executive Management and Scientific Advisory Board Appointments 2S1 Pharmaceuticals Announces New Executive Management and Scientific Advisory Board Appointments 3
(Date:7/26/2014)... “BRIC Sinuscopes Market Outlook to 2020,? provides key market ... value, in millions of US dollars, volume (in units) ... – Rigid Non-Video Sinuscopes. , The report also provides ... these market categories, and global corporate-level profiles of the ... related to the Sinuscopes market wherever available. , Overview ...
(Date:7/26/2014)... 26, 2014 Multiple sclerosis (MS), ... is an inflammatory disease in which the insulating ... spinal cord are damaged. This damage disrupts the ... communicate, resulting in a wide range of signs ... problems. Multiple sclerosis takes several forms, with new ...
(Date:7/26/2014)... Wa (PRWEB) July 26, 2014 According ... by Vkool.com, this is a comprehensive bodybuilding program that ... without using anabolic steroids . The program also ... muscle without cardio. , Vkool reveals in its ... and workouts that can help men get ripped and ...
(Date:7/25/2014)... 26, 2014 Dental Perfection, a Derby ... services including general dentistry, clear braces and much more, ... this year in Derby. The new practice, which is ... Medical Centre in Littleover, Derby. Patients may already pre-register ... The new dental practice, which is headed by Invisalign ...
(Date:7/25/2014)... 26, 2014 According to a ... by Product (vibration monitoring, thermography, ultrasound emission, lubricating ... Component, Application and Geography - Global Forecast to ... health monitoring market is expected to reach $2.50 ... 2020. , Browse 117 market data Tables and ...
Breaking Medicine News(10 mins):Health News:Sinuscopes Market in BRIC (Brazil, Russia, India & China) Forecast to 2020 Report Available at MarketOptimizer.org 2Health News:Sinuscopes Market in BRIC (Brazil, Russia, India & China) Forecast to 2020 Report Available at MarketOptimizer.org 3Health News:Sinuscopes Market in BRIC (Brazil, Russia, India & China) Forecast to 2020 Report Available at MarketOptimizer.org 4Health News:Multiple Sclerosis Therapeutics Clinical Trials Market Review H2 2014 Analysis Report Available at MarketOptimizer.org 2Health News:Multiple Sclerosis Therapeutics Clinical Trials Market Review H2 2014 Analysis Report Available at MarketOptimizer.org 3Health News:Multiple Sclerosis Therapeutics Clinical Trials Market Review H2 2014 Analysis Report Available at MarketOptimizer.org 4Health News:Metabolic Enhancement Training Review Exposes Scott Abel's Program for Bodybuilding – Vkool.com 2Health News:Metabolic Enhancement Training Review Exposes Scott Abel's Program for Bodybuilding – Vkool.com 3Health News:Derby Cosmetic Dentist Dental Perfection to Open New Practice in Littleover, Derby this September 2Health News:Machine Health Monitoring Market by Product, Component & Application Worth $2.50 Billion by 2020 - New Report by MarketsandMarkets 2Health News:Machine Health Monitoring Market by Product, Component & Application Worth $2.50 Billion by 2020 - New Report by MarketsandMarkets 3Health News:Machine Health Monitoring Market by Product, Component & Application Worth $2.50 Billion by 2020 - New Report by MarketsandMarkets 4
... ... of its new website, Herbal Fen Phen Lawyers ( http://www.herbalfenphenlawyers.com/ ). Herbal Fen Phen ... despite warnings from the FDA that herbal Fen Phen may be linked to serious ... death. , ...
... , OAKLAND, Calif., Aug. 7 Kaiser ... reported today a combined total operating revenue of $10.5 billion for ... the second quarter of last year. Operating income in the ... quarter of last year. Net non-operating income was $209 million ...
... , Senate Finance Committee Urged Not to ... , WASHINGTON, Aug. 7 America,s local and regional ... a provision imposing a 20% co-pay on laboratory services under Medicare. ... system, this provision would shift billions of dollars in costs to ...
... , PROVO, Utah, Aug. 7 Nu ... board of directors has declared a quarterly dividend of $0.115 per ... of record on Aug. 28, 2009. , , ... Inc. has been demonstrating its tradition of innovation through its comprehensive ...
... risk factors and patterns of development , FRIDAY, Aug. ... second grade for symptoms of depression may help better ... of Washington study shows. , Even though about ... developed more than a few symptoms of depression, the ...
... , , , , ... WBMD ) and HLTH Corporation (Nasdaq: HLTH ) today announced ... 29th Annual Global Growth Conference on Wednesday, August 12, 2009 at 1:00 ... the general public are invited to listen to a live audio broadcast ...
Cached Medicine News:Health News:Hissey Kientz Announces the Launch of Herbal Fen Phen Lawyers Website 2Health News:Hissey Kientz Announces the Launch of Herbal Fen Phen Lawyers Website 3Health News:Kaiser Foundation Health Plan and Hospitals Report Second Quarter 2009 Financial Results 2Health News:Kaiser Foundation Health Plan and Hospitals Report Second Quarter 2009 Financial Results 3Health News:Kaiser Foundation Health Plan and Hospitals Report Second Quarter 2009 Financial Results 4Health News:Seniors: Get Your Checkbooks Ready 2Health News:Signs of Depression Noted in Second Graders 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: